Evaluation of hirsutism

Última revisão: 30 Nov 2025
Última atualização: 24 Jul 2025

Resumo

Diagnósticos diferenciais

comuns

  • Polycystic ovary syndrome
  • Idiopathic hirsutism
Detalhes completos

Incomuns

  • Hyperprolactinemia
  • Nonclassic congenital adrenal hyperplasia
  • Cushing syndrome
  • Androgenic drugs
  • Androgen-secreting ovarian tumor
  • Ovarian hyperthecosis
  • Adrenocortical carcinoma
Detalhes completos

Colaboradores

Autores

Stephen L. Atkin, PhD, FRCP

Professor of Medicine

Head of School of Postgraduate Studies & Research

The Royal College of Surgeons in Ireland - Bahrain

Busaiteen

Bahrain

Declarações

SLA has no competing interests.

Thozhukat Sathyapalan, MD, MRCP FRCPE

Professor of Endocrinology/Honorary Consultant Endocrinologist

Academic Endocrinology, Diabetes and Metabolism

Hull York Medical School

Michael White Diabetes Centre

Hull Royal Infirmary

Hull

UK

Declarações

TS declares that he has received educational grants and clinical trials funding from Novo Nordisk, Eli Lillly, and Novartis.

Agradecimentos

Dr Stephen L. Atkin and Dr Thozhukat Sathyapalan would like to gratefully acknowledge Dr Shehzad Basaria and Dr Milena Braga-Basaria, the previous contributors to this topic.

Declarações

SB and MBB declared that they had no competing interests.

Revisores

Joe McKenna, MD

Professor of Investigative Endocrinology

University College

Dublin

Ireland

Divulgaciones

JM declares that he has no competing interests.

Udaya Kabadi, MD, FRCP(C), FACP, FACE

Director

Endocrinology

Department of Internal Medicine

VA Medical Center

University of Iowa

Iowa City

IA

Divulgaciones

UK declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1233-57.Texto completo  Resumen

Elliott J, Liu K, Motan T. Guideline no. 444: hirsutism: evaluation and treatment. J Obstet Gynaecol Can. 2023 Dec;45(12):102272. Resumen

Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023 Oct;120(4):767-93.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad